Pasithea Therapeutics holds annual shareholder meeting

• Pasithea Therapeutics held its annual meeting on Sept. 9, 2026.
• Shareholders backed the election of two directors.
• Investors ratified CBIZ CPAs as independent auditor for the fiscal year ending Dec. 31, 2026.
• Approval granted for a potential reverse stock split, if the board proceeds, at a 1-for-2 to 1-for-20 ratio.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pasithea Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-098405), on September 09, 2026, and is solely responsible for the information contained therein.